KUWAIT CITY, July 16: The Dasman Diabetes Institute (DDI) represented Kuwait at the 85th Annual Scientific Session of the American Diabetes Association (ADA), held recently in Chicago. This event, one of the world’s foremost gatherings of diabetes researchers, saw the institute's participation as the largest from the Arab world.

Dr. Faisal Al-Rifai, Acting Director General of DDI, highlighted the significance of the institute's involvement, noting the wide array of scientific lectures and research posters presented by the DDI team. He emphasized that the participation marked a key milestone in the institute's efforts to contribute to the global fight against diabetes.

In addition to the presentations, Dr. Al-Rifai mentioned that the conference also provided a valuable platform for DDI’s researchers to meet with representatives from leading international institutions. Discussions during these meetings focused on shared research interests, as well as opportunities for collaboration on future diabetes-related projects.

This engagement at the ADA conference is in line with the institute's broader vision to strengthen its global partnerships in cutting-edge diabetes research. The DDI, which operates under the Kuwait Foundation for the Advancement of Sciences (KFAS), aims to expand its research cooperation with prestigious universities and centers worldwide, contributing to the development of effective programs and solutions to combat diabetes and its complications.

By building on international collaboration and sharing expertise, the Dasman Diabetes Institute continues to enhance its role in advancing scientific knowledge and improving diabetes care globally.